Bart Barlogie

430 total citations
9 papers, 290 citations indexed

About

Bart Barlogie is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Bart Barlogie has authored 9 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Bart Barlogie's work include Multiple Myeloma Research and Treatments (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Bart Barlogie is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Bart Barlogie collaborates with scholars based in United States. Bart Barlogie's co-authors include Aubrey J. Hough, Guillermo A. Herrera, Lija Joseph, Xin Gu, Dixie Esseltine, James R. Berenson, Sundar Jagannath, Elizabeth Trehu, Kenneth C. Anderson and David Siegel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Bart Barlogie

8 papers receiving 283 citations

Peers

Bart Barlogie

MB

HEMAT

ONCOL

GENET

NEPHR

Tomáš Pika Czechia

David Siegel United States

Thomas G Martin United States

PR Greipp United States

Salli Fennessey United States

Serena Rocchi Italy

Amélie Bonaud France

Eugenio Lucia Italy

Agne Paner United States

Adrianna Henson United States

Tomáš Pika Czechia

Bart Barlogie

222 ×1.0

MB

224 ×1.2

HEMAT

129 ×1.2

ONCOL

68 ×1.1

GENET

31 ×0.7

NEPHR

Citations per year, relative to Bart Barlogie Bart Barlogie (= 1×) peers Tomáš Pika

Countries citing papers authored by Bart Barlogie

Since Specialization

Citations

This map shows the geographic impact of Bart Barlogie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Barlogie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Barlogie more than expected).

Fields of papers citing papers by Bart Barlogie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Barlogie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Barlogie. The network helps show where Bart Barlogie may publish in the future.

Co-authorship network of co-authors of Bart Barlogie

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Barlogie. A scholar is included among the top collaborators of Bart Barlogie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Barlogie. Bart Barlogie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Sawyer, Jeffrey R., Erming Tian, Christoph Heuck, et al.. (2014). Evidence of an Epigenetic Origin for High-Risk 1q21 Copy Number Aberrations in Multiple Myeloma. Blood. 124(21). 725–725.

2.

Qiang, Ya‐Wei, Bo Hu, Yu Chen, et al.. (2008). Bortezomib Induces Osteoblast Differentiation Via Wnt-Independent Activation of Beta-catenin/TCF Signaling. Blood. 112(11). 846–846. 4 indexed citations

3.

Zhan, Fenghuang, Bart Barlogie, Yongsheng Huang, et al.. (2006). A Gene Expression Signature of Benign Monoclonal Gammopathy Evident in Multiple Myeloma Is Linked to Good Prognosis.. Blood. 108(11). 3393–3393. 12 indexed citations

4.

Shaughnessy, John D., Fenghuang Zhan, Bart Burington, et al.. (2006). A Validated Gene Expression Signature of High Risk Multiple Myeloma Is Defined by Deregulated Expression of Genes Mapping to Chromosome 1.. Blood. 108(11). 111–111. 4 indexed citations

5.

Berenson, James R., Sundar Jagannath, Bart Barlogie, et al.. (2005). Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma. Cancer. 104(10). 2141–2148. 82 indexed citations

6.

Coleman, Elizabeth Ann, E. Anaissie, Sharon K. Coon, et al.. (2004). A randomized trial of home-based exercise for patients receiving aggressive treatment and epoetin alfa for multiple myeloma: Hemoglobin (Hb), transfusion, fatigue and performance as outcomes. Journal of Clinical Oncology. 22(14_suppl). 8026–8026. 1 indexed citations

7.

Herrera, Guillermo A., Lija Joseph, Xin Gu, Aubrey J. Hough, & Bart Barlogie. (2004). Renal Pathologic Spectrum in an Autopsy Series of Patients With Plasma Cell Dyscrasia. Archives of Pathology & Laboratory Medicine. 128(8). 875–879. 82 indexed citations

8.

Herrera, Guillermo A., Lija Joseph, Xin Gu, Aubrey J. Hough, & Bart Barlogie. (2004). Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia.. Archives of Pathology & Laboratory Medicine. 128(8). 875–9. 88 indexed citations

9.

Lim, Seah H., Ashraf Badros, C Lue, & Bart Barlogie. (2001). Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma. Cancer. 91(5). 900–908. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact